Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines

Journal of Virology

Volumn 74, Issue 23, 2000, Pages 11115-11120

  Yoo, L ^a   Speck, S H ^a  

^a Box 8118 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN; ESTRADIOL;

ARTICLE; B LYMPHOCYTE; CELL IMMORTALIZATION; CELL ISOLATION; CELL LINE; EPSTEIN BARR VIRUS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LATENT PERIOD; LYMPHOBLAST; MARMOSET; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; VIRUS GENE; VIRUS INFECTION; VIRUS MUTANT;

ANIMALS; CALLITHRIX; CELL LINE; ENHANCER ELEMENTS (GENETICS); EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; MUTATION; PROMOTER REGIONS (GENETICS); VIRUS LATENCY;

EID: 0034467099     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.23.11115-11120.2000     Document Type: Article

References (24)

1. Early events in Epstein-Barr virus infection of human B lymphocytes
2. Activation of the Epstein-Barr virus genome by 5-aza-cytidine in latently infected human lymphoid lines
3. A modified procedure for the propagation of wild-type Epstein-Barr virus in cultures of marmoset blood cells
4. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
5. In vitro transforming activity of EBV. I. Establishment and properties of two EBV strains (M81 and M72) produced by immortalized Callithrix jacchus lymphocytes
6. Molecular genetic analysis of Epstein-Barr virus Cp promoter function
7. Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15)
8. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes
9. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation
10. Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines
11. Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus
12. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate
13. Isolation of human T and B lymphocytes by E-rosette gradient centrifugation. Characterization of the isolated subpopulations
14. Enhancement of Epstein-Barr virus replication in producer cell lines by a combination of low temperature and corticosteroids
15. Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis-derived strains of Epstein-Barr virus released from transformed marmoset cells
16. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes
17. Regulation of EBNA gene transcription in lymphoblastoid cell lines: Characterization of sequences downstream of BCR2 (Cp)
18. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells
19. Characterization of Epstein-Barr virus recombinants with deletions of the BamHI C promoter
20. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation
21. Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection
22. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes
23. B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1
24. Persisting oncogenic herpesvirus induced by the tumour promoter TPA